M M Vellinga

Summary

Affiliation: VU University Medical Center
Country: The Netherlands

Publications

  1. ncbi Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients
    M M Vellinga
    Department of Neurology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
    Neurology 70:1150-1. 2008
  2. ncbi Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement
    Machteld M Vellinga
    Department of Neurology, University Medical Centre, Amsterdam, The Netherlands
    Brain 131:800-7. 2008
  3. ncbi Clinical correlations of brain lesion distribution in multiple sclerosis
    M M Vellinga
    Department of Neurology, MS Center Amsterdam, Amsterdam, The Netherlands
    J Magn Reson Imaging 29:768-73. 2009
  4. ncbi Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI to demonstrate diffuse inflammation in the normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients: an exploratory study
    Machteld M Vellinga
    Department of Neurology, MS Centre Amsterdam, Amsterdam, The Netherlands
    J Magn Reson Imaging 29:774-9. 2009
  5. ncbi Genetic correlations of brain lesion distribution in multiple sclerosis: an exploratory study
    M H Sombekke
    VU University Medical Center, Department of Neurology, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
    AJNR Am J Neuroradiol 32:695-703. 2011

Detail Information

Publications5

  1. ncbi Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients
    M M Vellinga
    Department of Neurology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
    Neurology 70:1150-1. 2008
  2. ncbi Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement
    Machteld M Vellinga
    Department of Neurology, University Medical Centre, Amsterdam, The Netherlands
    Brain 131:800-7. 2008
    ..The use of USPIO-enhanced MRI is likely to lead to more insight in the pluriformity of inflammation in multiple sclerosis...
  3. ncbi Clinical correlations of brain lesion distribution in multiple sclerosis
    M M Vellinga
    Department of Neurology, MS Center Amsterdam, Amsterdam, The Netherlands
    J Magn Reson Imaging 29:768-73. 2009
    ..Hypothesizing that symptomatology may partly be determined by lesion location, this retrospective study explored relations between lesion location and disability using voxelwise analyses in standard space...
  4. ncbi Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI to demonstrate diffuse inflammation in the normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients: an exploratory study
    Machteld M Vellinga
    Department of Neurology, MS Centre Amsterdam, Amsterdam, The Netherlands
    J Magn Reson Imaging 29:774-9. 2009
    ..USPIO have been shown to visualize the cellular component of inflammation in focal MS lesions. In this study, we aimed to explore USPIO as a marker for the more diffuse inflammation in MS NAWM, using quantitative MRI...
  5. ncbi Genetic correlations of brain lesion distribution in multiple sclerosis: an exploratory study
    M H Sombekke
    VU University Medical Center, Department of Neurology, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
    AJNR Am J Neuroradiol 32:695-703. 2011
    ..We hypothesized that spatial distribution may be partially driven by genetic predisposition, and we aimed to explore relations among candidate genes and the spatial distribution of white matter brain lesions in MS...